Performance slump takes toll on Novartis' CEO's 2022 payout
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Vasant Narasimhan | Novartis
Vas Narasimhan, CEO de la farmaceútica Novartis | XLSemanal
Watch Novartis CEO on Acquisitions, AI, Weight-Loss Drugs - Bloomberg
Novartis prevé destinar más de 8.800 millones a la compra de otras empresas en 2019 | PlantaDoce
Novartis inicia una revisión exhaustiva de Beovu por sus efectos adversos
Basel is very open to newcomers - Basel Area Business & Innovation
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
30 fotos e imágenes de Novartis Ceo Vas Narasimhan Interview - Getty Images
El CEO de Novartis advierte: una vacuna no bastará para combatir el COVID - Infobae
It'll take more than vaccines to fight covid-19, says Novartis CEO Vas Narasimhan | Mint
How to get ordinary people to do extraordinary things: Novartis CEO Vas Narasimhan on the multiplier
Biotech can become a powerhouse in India': Novartis' Narasimhan | Mint
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and more - STAT
Novartis CEO on how to price lifesaving cell and gene therapies
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Vas Narasimhan, chief executive officer of Novartis AG, during an... Fotografía de noticias - Getty Images
Novartis CEO Vas Narasimhan: Our medicines are starting to take market share and deliver on promises - YouTube
Vas Narasimhan Ceo Swiss Pharmaceutical Group Foto de stock de contenido editorial - Imagen de stock | Shutterstock
Novartis CEO's take-home pay jumps 59%. But there's one miss—ethics | Fierce Pharma
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
